ESC 365 - Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Open Access

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Sponsored by Bayer AG

Date: 28 August 2017

Time: 12:45 - 13:45

Session

5 presentations in this session

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Professor R. Mehran (New York, US)

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Milan, IT)

5 speakers from this session

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

28 presentations

1 follower

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

35 presentations

0 follower

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

27 presentations

1 follower

Doctor Christian Ruff

Brigham and Women's Hospital, Boston (United States of America)

20 presentations

0 follower

Doctor Riccardo Cappato

Humanitas Research Hospital, Milan (Italy)

12 presentations

0 follower

This platform is supported by